Advertisement

Pharmacological Treatment for Phobias and Anxiety Disorders

  • Michael H. Bloch
  • Joseph F. McGuire
Chapter

Abstract

Anxiety disorders in childhood are quite ­common, affecting between 6 and 20% of all children (Costello, Mustillo, Erkanli, Keeler, & Angold, 2003). Anxiety disorders can adversely impact social and academic functioning as well as self-esteem (Mendlowicz & Stein, 2000). Children with anxiety disorders grow up to having greater rates of depression, new anxiety disorders, substance abuse, educational underachievement, and suicide attempts than the general population (Achenbach, Howell, McConaughy, & Stanger, 1995; Ferdinand, Verhulst, & Wiznitzer, 1995; Pine, Cohen, Gurley, Brook, & Ma, 1998; Woodward & Fergusson, 2001).

Keywords

Anxiety Disorder Cognitive Behavioral Therapy Selective Serotonin Reuptake Inhibitor Separation Anxiety Disorder Childhood Anxiety Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

The authors acknowledge the National Institute of Mental Health support of the Yale Child Study Center Research Training Program (MHB), NARSAD (MHB), Trichotillomania Learning Center (MHB), the National Institutes of Health Loan Repayment Program (MHB), and the APIRE/Eli Lilly Psychiatric Research Fellowship (MHB).

References

  1. Aaron, J., Zaglul, H., & Emery, R. E. (1999). Posttraumatic stress in children following acute physical injury. Journal of Pediatric Psychology, 24(4), 335–343.PubMedCrossRefGoogle Scholar
  2. Achenbach, T. M., Howell, C. T., McConaughy, S. H., & Stanger, C. (1995). Six-year predictors of problems in a national sample: III. Transitions to young adult syndromes. Journal of the American Academy of Child and Adolescent Psychiatry, 34(5), 658–669.PubMedCrossRefGoogle Scholar
  3. Ahmad, A., Larsson, B., & Sundelin-Wahlsten, V. (2007). EMDR treatment for children with PTSD: Results of a randomized controlled trial. Nordic Journal of Psychiatry, 61(5), 349–354.PubMedCrossRefGoogle Scholar
  4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association.Google Scholar
  5. Barbanti, P., & Fabbrini, G. (2004). Migraine and Tourette syndrome. Archives of Neurology, 61(4), 606–607; author reply 607.Google Scholar
  6. Beidel, D. C., Turner, S. M., Sallee, F. R., Ammerman, R. T., Crosby, L. A., & Pathak, S. (2007). SET-C versus fluoxetine in the treatment of childhood social phobia. Journal of the American Academy of Child and Adolescent Psychiatry, 46(12), 1622–1632.PubMedCrossRefGoogle Scholar
  7. Birmaher, B., Axelson, D. A., Monk, K., Kalas, C., Clark, D. B., Ehmann, M., et al. (2003). Fluoxetine for the treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 42(4), 415–423.PubMedCrossRefGoogle Scholar
  8. Bloch, M. H., Craiglow, B. G., Landeros-Weisenberger, A., Dombrowski, P. A., Panza, K. E., Peterson, B. S., et al. (2009). Predictors of early adult outcome in pediatric-onset obsessive-compulsive disorder. Pediatrics, 124(4), 1085–1093.PubMedCrossRefGoogle Scholar
  9. Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., Coric, V., Bracken, M. B., & Leckman, J. F. (2006). A systematic review: Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Molecular Psychiatry, 11(7), 622–632.PubMedCrossRefGoogle Scholar
  10. Bloch, M. H., McGuire, J., Landeros-Weisenberger, A., Leckman, J. F., & Pittenger, C. P. (2010). Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Molecular Psychiatry, 15(8), 850–855.PubMedCrossRefGoogle Scholar
  11. Bollini, P., Pampallona, S., Tibaldi, G., Kupelnick, B., & Munizza, C. (1999). Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials. The British Journal of Psychiatry, 174, 297–303.PubMedCrossRefGoogle Scholar
  12. Brady, K. T., Pearlstein, T., & Asnis, G. M. (2000). Double-blind, placebo-controlled study of the efficacy and safety of sertraline for posttraumatic stress disorder. JAMA, 283, 545–554.CrossRefGoogle Scholar
  13. Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA, 297(15), 1683–1696.PubMedCrossRefGoogle Scholar
  14. Cohen, J. A., Deblinger, E., Mannarino, A. P., & Steer, R. A. (2004). A multisite, randomized controlled trial for children with sexual abuse-related PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 43(4), 393–402.PubMedCrossRefGoogle Scholar
  15. Cohen, J. A., Mannarino, A. P., & Deblinger, E. (2006). Treating trauma and traumatic grief in children and adolescents. New York: Guilford.Google Scholar
  16. Cohen, J. A., Mannarino, A. P., Perel, J. M., & Staron, V. (2007). A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 46(7), 811–819.PubMedCrossRefGoogle Scholar
  17. Connolly, S. D., & Bernstein, G. A. (2007). Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 46(2), 267–283.PubMedCrossRefGoogle Scholar
  18. Connor, K. M., Sutherland, S. M., Tupler, L. A., Malik, M. L., & Davidson, J. R. (1999). Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. The British Journal of Psychiatry, 175, 17–22.PubMedCrossRefGoogle Scholar
  19. Costello, E. J., Erkanli, A., Fairbank, J. A., & Angold, A. (2002). The prevalence of potentially traumatic events in childhood and adolescence. Journal of Traumatic Stress, 15(2), 99–112.PubMedCrossRefGoogle Scholar
  20. Costello, E. J., Mustillo, S., Erkanli, A., Keeler, G., & Angold, A. (2003). Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry, 60(8), 837–844.PubMedCrossRefGoogle Scholar
  21. Ferdinand, R. F., Verhulst, F. C., & Wiznitzer, M. (1995). Continuity and change of self-reported problem behaviors from adolescence into young adulthood. Journal of the American Academy of Child and Adolescent Psychiatry, 34(5), 680–690.PubMedCrossRefGoogle Scholar
  22. Fineberg, N. A., Pampaloni, I., Pallanti, S., Ipser, J., & Stein, D. J. (2007). Sustained response versus relapse: The ­pharmacotherapeutic goal for obsessive-­compulsive disorder. International Clinical Psychopharmacology, 22(6), 313–322.PubMedCrossRefGoogle Scholar
  23. Finkelhor, D., Hamby, S. L., Ormrod, R., & Turner, H. (2005). The Juvenile Victimization Questionnaire: Reliability, validity, and national norms. Child Abuse & Neglect, 29(4), 383–412.CrossRefGoogle Scholar
  24. Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Farrell, C., Wagner, K. D., et al. (2003). Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: Is the use of exclusion criteria empirically supported in randomized clinical trials? Journal of Child and Adolescent Psychopharmacology, 13(Suppl 1), S19–S29.PubMedCrossRefGoogle Scholar
  25. Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Martin, A., Spencer, T., et al. (2003). Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. The American Journal of Psychiatry, 160(11), 1919–1928.PubMedCrossRefGoogle Scholar
  26. Geller, D. A., Hoog, S. L., Heiligenstein, J. H., Ricardi, R. K., Tamura, R., Kluszynski, S., et al. (2001). Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40(7), 773–779.PubMedCrossRefGoogle Scholar
  27. Gellar, D. A., Wagner, K. D., Emslie, G., Murphy, T., Carpenter, D. J., Wetherhold, E., Perera, P., Machin, A., Garnier, C. (2004). Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 43(11), 1387–1396.Google Scholar
  28. Goodman, W. K., Murphy, T. K., & Storch, E. A. (2007). Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl), 191(1), 87–96.CrossRefGoogle Scholar
  29. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Delgado, P., Heninger, G. R., et al. (1989). The Yale-Brown Obsessive Compulsive Scale. II. Validity. Archives of General Psychiatry, 46(11), 1012–1016.PubMedGoogle Scholar
  30. Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., et al. (1989). The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry, 46(11), 1006–1011.PubMedGoogle Scholar
  31. Graae, F., Milner, J., Rizzotto, L., & Klein, R. G. (1994). Clonazepam in childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 33(3), 372–376.PubMedCrossRefGoogle Scholar
  32. Greist, J. H., Bandelow, B., Hollander, E., Marazziti, D., Montgomery, S. A., Nutt, D. J., et al. (2003). WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectrums, 8(8 Suppl 1), 7–16.PubMedGoogle Scholar
  33. Hammad, T. A. (2004). Review and evaluation of clinical data. Washington, DC, Food and Drug Administration, Aug 16,2004. Http://www.fda.gov/ohrms/dockets/ac/04/.
  34. Harmon, R. J., & Riggs, P. D. (1996). Clonidine for posttraumatic stress disorder in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 35(9), 1247–1249.PubMedCrossRefGoogle Scholar
  35. Hollander, E., Allen, A., Steiner, M., Wheadon, D. E., Oakes, R., & Burnham, D. B. (2003). Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine. The Journal of Clinical Psychiatry, 64(9), 1113–1121.PubMedCrossRefGoogle Scholar
  36. Horrigan, J. P. (1996). Guanfacine for PTSD nightmares. Journal of the American Academy of Child and Adolescent Psychiatry, 35(8), 975–976.PubMedCrossRefGoogle Scholar
  37. Kashani, J. H., & Orvaschel, H. (1990). A community study of anxiety in children and adolescents. The American Journal of Psychiatry, 147(3), 313–318.PubMedGoogle Scholar
  38. Kessler, R. C., Sonnega, A., Bromet, E., Hughes, M., & Nelson, C. B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52(12), 1048–1060.PubMedGoogle Scholar
  39. Lieberman, A. F., Van Horn, P., & Ippen, C. G. (2005). Toward evidence-based treatment: Child-parent psychotherapy with preschoolers exposed to marital violence. Journal of the American Academy of Child and Adolescent Psychiatry, 44(12), 1241–1248.PubMedCrossRefGoogle Scholar
  40. Liebowitz, M. R., Stein, M. B., Tancer, M., Carpenter, D., Oakes, R., & Pitts, C. D. (2002). A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder. The Journal of Clinical Psychiatry, 63(1), 66–74.PubMedCrossRefGoogle Scholar
  41. March, J. S., Biederman, J., Wolkow, R., Safferman, A., Mardekian, J., Cook, E. H., et al. (1998). Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial. JAMA, 280(20), 1752–1756.PubMedCrossRefGoogle Scholar
  42. March, J. S., Entusah, A. R., Rynn, M., Albano, A. M., & Tourian, K. A. (2007). A randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biological Psychiatry, 62(10), 1149–1154.PubMedCrossRefGoogle Scholar
  43. March, J. S., Parker, J. D., Sullivan, K., Stallings, P., & Conners, C. K. (1997). The Multidimensional Anxiety Scale for Children (MASC): Factor structure, reliability, and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36(4), 554–565.PubMedCrossRefGoogle Scholar
  44. Martin, A., Young, C., Leckman, J. F., Mukonoweshuro, C., Rosenheck, R., & Leslie, D. (2004). Age effects on antidepressant-induced manic conversion. Archives of Pediatrics & Adolescent Medicine, 158(8), 773–780.CrossRefGoogle Scholar
  45. Mendlowicz, M. V., & Stein, M. B. (2000). Quality of life in individuals with anxiety disorders. The American Journal of Psychiatry, 157(5), 669–682.PubMedCrossRefGoogle Scholar
  46. Nader, K. O., Kriegler, J. A., Blake, D. D., Pynoos, R. S., Newman, E., & Weathers, F. W. (1996). Clinician administered PTSD Scale for children and adolescents for DSM-IV. Los Angeles, CA: National Center for PTSD and UCLA Trauma Psychiatry Program, Department of Psychiatry, UCLA School of Medicine.Google Scholar
  47. Najavits, L. M., Gallop, R. J., & Weiss, R. D. (2006). Seeking safety therapy for adolescent girls with PTSD and substance use disorder: A randomized controlled trial. The Journal of Behavioral Health Services & Research, 33(4), 453–463.CrossRefGoogle Scholar
  48. Pallanti, S., Hollander, E., Bienstock, C., Koran, L., Leckman, J., Marazziti, D., et al. (2002). Treatment non-response in OCD: Methodological issues and operational definitions. The International Journal of Neuropsychopharmacology, 5(2), 181–191.PubMedCrossRefGoogle Scholar
  49. Pine, D. S., & Cohen, J. A. (2002). Trauma in children and adolescents: Risk and treatment of psychiatric sequelae. Biological Psychiatry, 51(7), 519–531.PubMedCrossRefGoogle Scholar
  50. Pine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998). The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Archives of General Psychiatry, 55(1), 56–64.PubMedCrossRefGoogle Scholar
  51. POTS. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA, 292, 1969–1976.CrossRefGoogle Scholar
  52. Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder. Retrieved February 28, 2010, from http://www.aacap.org/galleries/PracticeParameters/Final%20for%20Web%20December%202009%20PTSD.pdf
  53. Reich, D. B., Winternitz, S., Hennen, J., Watts, T., & Stanculescu, C. (2004). A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. The Journal of Clinical Psychiatry, 65(12), 1601–1606.PubMedCrossRefGoogle Scholar
  54. Reinblatt, S. P., & Walkup, J. T. (2005). Psychopharmaco-logic treatment of pediatric anxiety disorders. Child and Adolescent Psychiatric Clinics of North America, 14(4), 877–908, x.Google Scholar
  55. Research Unit on Pediatric Psychopharmacology Anxiety Study Group, Fluvoxamine for the treatment of anxiety disorders in children and adolescents, N Engl J Med 344 (2001), pp. 1279–1285.Google Scholar
  56. Riddle, M. A., Reeve, E. A., Yaryura-Tobias, J. A., Yang, H. M., Claghorn, J. L., Gaffney, G., et al. (2001). Fluvoxamine for children and adolescents with obsessive-compulsive disorder: A randomized, controlled, multicenter trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 222–229.PubMedCrossRefGoogle Scholar
  57. Robb, A., Cueva, J., Sporn, J., Yang, R., & Vanderburg, D. (2008). Efficacy of sertraline in childhood posttraumatic stress disorder. Paper presented at the American Academy of Child and Adolescent Psychiatry, Chicago, IL.Google Scholar
  58. Rothbaum, B. O., Kozak, M. J., Foa, E. B., & Whitaker, D. J. (2001). Posttraumatic stress disorder in rape victims: Autonomic habituation to auditory stimuli. Journal of Traumatic Stress, 14(2), 283–293.PubMedCrossRefGoogle Scholar
  59. Rupp (2001). Research Unit on Pediatric Psycho­pharmacology Anxiety Study Group, Fluvoxamine for the treatment of anxiety disorders in children and adolescents, N Engl J Med 344, pp.1279–1289Google Scholar
  60. Rynn, M. A., Siqueland, L., & Rickels, K. (2001). Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. The American Journal of Psychiatry, 158(12), 2008–2014.PubMedCrossRefGoogle Scholar
  61. Rynn, M. A., Riddle, M. A., Yeung, P. P., Kunz, N. R. (2007). Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. Am J Psychiatry. 164(2), 290–300.Google Scholar
  62. Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., et al. (1997). Children’s Yale-Brown Obsessive Compulsive Scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36(6), 844–852.PubMedCrossRefGoogle Scholar
  63. Scheeringa, M. S., Zeanah, C. H., Myers, L., & Putnam, F. W. (2003). New findings on alternative criteria for PTSD in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 42(5), 561–570.PubMedCrossRefGoogle Scholar
  64. Simeon, J. G., Ferguson, H. B., Knott, V., Roberts, N., Gauthier, B., Dubois, C., et al. (1992). Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 31(1), 29–33.PubMedCrossRefGoogle Scholar
  65. Simpson, H. B., Foa, E. B., Liebowitz, M. R., Ledley, D. R., Huppert, J. D., Chaill, S., et al. (2008). A randomized, controlled trail of cognitie-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Am J Psychiatry. 165(5), 621–30.Google Scholar
  66. Stathis, S., Martin, G., & McKenna, J. G. (2005). A preliminary case series on the use of quetiapine for posttraumatic stress disorder in juveniles within a youth detention center. Journal of Clinical Psychophar­macology, 25(6), 539–544.PubMedCrossRefGoogle Scholar
  67. Stein, M. B., Kline, N. A., & Matloff, J. L. (2002). Adjunctive olanzapine for SSRI-resistant combat-related PTSD: A double-blind, placebo-controlled study. The American Journal of Psychiatry, 159(10), 1777–1779.PubMedCrossRefGoogle Scholar
  68. Steinberg, A. M., Brymer, M. J., Decker, K. B., & Pynoos, R. S. (2004). The University of California at Los Angeles Post-traumatic Stress Disorder Reaction Index. Current Psychiatry Reports, 6(2), 96–100.PubMedCrossRefGoogle Scholar
  69. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The New England Journal of Medicine, 344(17), 1279–1285.CrossRefGoogle Scholar
  70. Trowell, J., Kolvin, I., Weeramanthri, T., Sadowski, H., Berelowitz, M., Glaser, D., et al. (2002). Psychotherapy for sexually abused girls: Psychopathological outcome findings and patterns of change. The British Journal of Psychiatry, 180, 234–247.PubMedCrossRefGoogle Scholar
  71. van der Kolk, B. A., Dreyfuss, D., Michaels, M., Shera, D., Berkowitz, R., Fisler, R., et al. (1994). Fluoxetine in posttraumatic stress disorder. The Journal of Clinical Psychiatry, 55(12), 517–522.PubMedGoogle Scholar
  72. Wagner, K. D., Berard, R., Stein, M. B., Wetherhold, E., Carpenter, D. J., Perera, P., et al. (2004). A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Archives of General Psychiatry, 61(11), 1153–1162.PubMedCrossRefGoogle Scholar
  73. Walkup, J. T., Albano, A. M., Piacentini, J., Birmaher, B., Compton, S. N., Sherrill, J. T., et al. (2008). Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. The New England Journal of Medicine, 359(26), 2753–2766.PubMedCrossRefGoogle Scholar
  74. Woodward, L. J., & Fergusson, D. M. (2001). Life course outcomes of young people with anxiety disorders in adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 40(9), 1086–1093.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Yale Child Study CenterYale University School of MedicineNew HavenUSA

Personalised recommendations